Sigachi Industries Limited (SIGACHI.NS)
INR 37.84
(-0.6%)
INR 37.84
(-0.6%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.53 Billion INR | 140.19% |
| 2022 | 1.05 Billion INR | 78.56% |
| 2021 | 590.2 Million INR | 50.53% |
| 2020 | 392.07 Million INR | -12.01% |
| 2019 | 445.58 Million INR | -4.34% |
| 2018 | 465.79 Million INR | 1.38% |
| 2017 | 459.46 Million INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | -4.41 Billion INR | -274.23% |
| 2023 FY | 2.53 Billion INR | 140.19% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 2.39 Billion INR | 0.0% |
| 2023 Q4 | 2.53 Billion INR | 0.0% |
| 2022 Q4 | 1.05 Billion INR | 0.0% |
| 2022 FY | 1.05 Billion INR | 78.56% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 1.02 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2021 Q1 | 481.81 Million INR | 22.89% |
| 2021 Q4 | 590.2 Million INR | 0.0% |
| 2021 FY | 590.2 Million INR | 50.53% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q2 | 596.38 Million INR | 23.78% |
| 2020 Q4 | 392.07 Million INR | 0.0% |
| 2020 Q1 | - INR | 0.0% |
| 2020 FY | 392.07 Million INR | -12.01% |
| 2019 FY | 445.58 Million INR | -4.34% |
| 2018 FY | 465.79 Million INR | 1.38% |
| 2017 FY | 459.46 Million INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Aarey Drugs & Pharmaceuticals Limited | 1.72 Billion INR | -46.98% |
| Aarti Drugs Limited | 11.5 Billion INR | 77.997% |
| Aarti Pharmalabs Limited | 8.25 Billion INR | 69.321% |
| Ajanta Pharma Limited | 10.71 Billion INR | 76.366% |
| Alembic Limited | 1.43 Billion INR | -76.752% |
| Alkem Laboratories Limited | 48.6 Billion INR | 94.792% |
| Alembic Pharmaceuticals Limited | 16.27 Billion INR | 84.446% |
| AstraZeneca Pharma India Limited | 3.66 Billion INR | 30.861% |
| Bal Pharma Limited | 2.51 Billion INR | -0.796% |
| Biofil Chemicals and Pharmaceuticals Limited | 288.79 Million INR | -776.48% |
| Bliss GVS Pharma Limited | 2.1 Billion INR | -20.031% |
| Brooks Laboratories Limited | 248.6 Million INR | -918.204% |
| Bafna Pharmaceuticals Limited | 652.27 Million INR | -288.065% |
| Caplin Point Laboratories Limited | 3.5 Billion INR | 27.794% |
| Divi's Laboratories Limited | 18.99 Billion INR | 86.671% |
| Eris Lifesciences Limited | 38.26 Billion INR | 93.385% |
| Granules India Limited | 22.95 Billion INR | 88.973% |
| Ind-Swift Limited | 13.45 Billion INR | 81.184% |
| Jagsonpal Pharmaceuticals Limited | 296.76 Million INR | -752.967% |
| J. B. Chemicals & Pharmaceuticals Limited | 10.7 Billion INR | 76.361% |
| Jubilant Pharmova Limited | 61.27 Billion INR | 95.869% |
| Kilitch Drugs (India) Limited | 643.88 Million INR | -293.125% |
| Medicamen Biotech Limited | 940.36 Million INR | -169.178% |
| Medico Remedies Limited | 438.24 Million INR | -477.593% |
| Wockhardt Limited | 39.87 Billion INR | 93.651% |
| Orchid Pharma Limited | 3.84 Billion INR | 34.152% |
| RPG Life Sciences Limited | 1.38 Billion INR | -83.398% |
| Shilpa Medicare Limited | 12.93 Billion INR | 80.427% |
| Solara Active Pharma Sciences Limited | 14.09 Billion INR | 82.037% |
| Unichem Laboratories Limited | 8.06 Billion INR | 68.631% |
| Vaishali Pharma Limited | 371.16 Million INR | -581.982% |
| Wanbury Limited | 3.15 Billion INR | 19.783% |
| Zydus Lifesciences Limited | 71.79 Billion INR | 96.474% |
| FDC Limited | 3.7 Billion INR | 31.757% |
| Amrutanjan Health Care Limited | 783.82 Million INR | -222.938% |
| Bajaj HealthCare Limited | 4.86 Billion INR | 47.998% |
| Dr. Reddy's Laboratories Limited | 106.96 Billion INR | 97.634% |
| Glenmark Life Sciences Limited | 5.18 Billion INR | 51.142% |
| Ind-Swift Laboratories Limited | 2.28 Billion INR | -10.562% |
| Laurus Labs Limited | 42.71 Billion INR | 94.074% |
| Mangalam Drugs & Organics Limited | 1.97 Billion INR | -28.08% |
| Nectar Lifesciences Limited | 11.21 Billion INR | 77.436% |
| Par Drugs and Chemicals Limited | 159.79 Million INR | -1484.11% |
| Hester Biosciences Limited | 3.59 Billion INR | 29.584% |
| Ipca Laboratories Limited | 33.74 Billion INR | 92.498% |
| Venus Remedies Limited | 1.39 Billion INR | -81.739% |
| ZIM Laboratories Limited | 2.08 Billion INR | -21.651% |
| Aurobindo Pharma Limited | 152.2 Billion INR | 98.337% |
| Morepen Laboratories Limited | 4.45 Billion INR | 43.242% |
| Neuland Laboratories Limited | 5.49 Billion INR | 53.965% |
| Sequent Scientific Limited | 8.27 Billion INR | 69.408% |
| Suven Pharmaceuticals Limited | 2.03 Billion INR | -24.434% |
| Valiant Laboratories Limited | 1.05 Billion INR | -139.191% |
| Windlas Biotech Limited | 1.76 Billion INR | -43.602% |
| Hikal Limited | 12.99 Billion INR | 80.521% |
| Innova Captab Limited | 4.89 Billion INR | 48.34% |
| Procter & Gamble Health Limited | 2.56 Billion INR | 1.169% |
| Themis Medicare Limited | 1.88 Billion INR | -34.106% |
| IOL Chemicals and Pharmaceuticals Limited | 6.32 Billion INR | 60.005% |
| Mankind Pharma Limited | 23.87 Billion INR | 89.398% |
| Glenmark Pharmaceuticals Limited | 65.11 Billion INR | 96.112% |
| Sakar Healthcare Limited | 1.26 Billion INR | -100.372% |
| Albert David Limited | 1.15 Billion INR | -120.09% |
| Lupin Limited | 96.23 Billion INR | 97.37% |
| Gufic Biosciences Limited | 5.59 Billion INR | 54.797% |
| Sun Pharmaceutical Industries Limited | 183.56 Billion INR | 98.621% |
| Lincoln Pharmaceuticals Limited | 1.07 Billion INR | -135.566% |
| Syncom Formulations (India) Limited | 1.16 Billion INR | -117.237% |
| Piramal Enterprises Limited | 560.47 Billion INR | 99.548% |
| Torrent Pharmaceuticals Limited | 82.05 Billion INR | 96.915% |
| NATCO Pharma Limited | 10.53 Billion INR | 75.966% |
| Suven Life Sciences Limited | 148.62 Million INR | -1603.168% |
| Krebs Biochemicals & Industries Limited | 2.97 Billion INR | 14.884% |
| Strides Pharma Science Limited | 37.68 Billion INR | 93.282% |
| Indoco Remedies Limited | 10.34 Billion INR | 75.525% |
| Alpa Laboratories Limited | 307.12 Million INR | -724.189% |
| Lasa Supergenerics Limited | 541.92 Million INR | -367.088% |
| Sun Pharma Advanced Research Company Limited | 3.89 Billion INR | 34.977% |